Have a personal or library account? Click to login
Antibiotic resistance, biofilm forming ability, and clonal profiling of clinical isolates of Staphylococcus aureus from southern and northeastern India Cover

Antibiotic resistance, biofilm forming ability, and clonal profiling of clinical isolates of Staphylococcus aureus from southern and northeastern India

Open Access
|Aug 2022

Figures & Tables

Figure 1

Sample source distribution of isolates from (A) Tamil Nadu and (B) Mizoram.
Sample source distribution of isolates from (A) Tamil Nadu and (B) Mizoram.

Figure 2

Strength of biofilm formation by the isolates from Tamil Nadu and Mizoram.
Strength of biofilm formation by the isolates from Tamil Nadu and Mizoram.

PCR primers used in the present study

No.Primer namePrimerReference
1mecA – F5′-TCACCAGGTTCAAC[Y]CAAAA-3′[17]
2mecA – R5′-CCTGAATC[W]GCTAATAATATTTC-3′
3mecC – F5′-GGGTTCAGCCAGATTCATTTGT-3′[18]
4mecC – R5′-GTACTGTTGCTTCGTTCAATGG-3′
5vanAB – F5′-GTAGGCTGCGATATTCAAAGC-3′[19]
6vanA – R5′-CGATTCAATTGCGTAGTCCAA-3′
7vanB – F5′-GCCGACAATCAAATCATCCTC-3′
8vanC1 – F5′-TGGTATTGGTATCAAGGAAACC-3′
9vanC1 – R5′-AGATTGGAGCGCTGTTTTGTC-3′
10vanC23 – F5′-CAGCAGCCATTGGCGTACAA-3′
11vanC23 – R5′-CAAGCAGTTTTTGTAGTAGTTC-3′
12blaZ – F5′-TTCAACACCTGCTGCTTTC-3′[20]
13blaZ – R5′-CACTCTTGGCGGTTTCAC-3′

ERIC-PCR cluster analysis, isolate distribution, and methicillin resistance of isolates from Tamil Nadu and Mizoram

Tamil NaduMizoram


Cluster groupNo. of isolates within the clusterNo. of MRSACluster groupNo. of isolates within the clusterNo. of MRSA
Cluster I11Cluster I1910
Cluster II31Cluster II156
Cluster III63Cluster III2111
Cluster IV10Cluster IV2312
Cluster V32Cluster V51
Cluster VI11Cluster VI11
Cluster VII9955Cluster VII21
Cluster VIII50Cluster VIII11

Antibiotic resistance by disk diffusion of isolates from Tamil Nadu and Mizoram

AntibioticAntibiotic classAntibiotic resistance of isolates from Tamil Nadun (%)Antibiotic resistance of isolates from Mizoramn (%)

RSRS
Oxacillinβ-lactam66 (56)53 (45)43 (49)44 (51)
Penicillinβ-lactam117 (98)2 (2)86 (99)1 (1)
Cefoxitinβ-lactam91 (76)28 (24)70 (81)17 (20)
CiprofloxacinFluoroquinolone98 (82)21 (18)65 (75)22 (25)
LevofloxacinFluoroquinolone66 (56)53 (45)61 (70)26 (30)
OfloxacinFluoroquinolone75 (63)44 (37)57 (66)30 (35)
TetracyclineTetracycline47 (40)72 (61)27 (31)60 (69)
ErythromycinMacrolide104 (87)15 (13)60 (69)27 (31)
ClindamycinLincosamide34 (29)85 (71)39 (45)48 (55)
LinezolidOxazolidinone16 (13)103 (87)12 (14)75 (86)
GentamicinAminoglycoside73 (61)46 (39)30 (35)57 (66)
DOI: https://doi.org/10.2478/abm-2022-0023 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 191 - 199
Published on: Aug 31, 2022
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2022 Archana Loganathan, Ramesh Nachimuthu, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.